Scott P. Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Scott P. Brown has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Palmer
BASF SE, Carl-Bosch-Straße 38, 67056 Ludwigshafen am Rhein, Germany
1 shared publication - Brian Lahue
Computational and Structural Chemistry, Merck & Co., Inc., Boston, Massachusetts 02115, United States
1 shared publication - Christos A. Nicolaou
Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States
1 shared publication - Connor W. Coley
Massachusetts Institute of Technology
1 shared publication - Constantine Kreatsoulas
GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States
1 shared publication - Daniel J. Griffin
Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States
1 shared publication
Latest Publications
- Open Access
- 3 April 2020
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (16) , 8667-8682
Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis
Artificial intelligence and machine learning have demonstrated their potential role in predictive chemistry and synthetic planning of small molecules; there are at least a few reports of companies employing in silico synthetic planning into their overall approach to accessing target molecules. A data-driven synthesis planning program is one component being developed and evaluated by the Machine Learning for Pharmaceutical Discovery and Synthesis (MLPDS) consortium, comprising MIT and 13 chemical and pharmaceutical company members. Together, we wrote this perspective to share how we think predictive models can be integrated into medicinal chemistry synthesis workflows, how they are currently used within MLPDS member companies, and the outlook for this field.
- 3 April 2020
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (16) , 8667-8682
Open AccessCurrent and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis
Artificial intelligence and machine learning have demonstrated their potential role in predictive chemistry and synthetic planning of small molecules; there are at least a few reports of companies employing in silico synthetic planning into their overall approach to accessing target molecules. A data-driven synthesis planning program is one component being developed and evaluated by the Machine Learning for Pharmaceutical Discovery and Synthesis (MLPDS) consortium, comprising MIT and 13 chemical and pharmaceutical company members. Together, we wrote this perspective to share how we think predictive models can be integrated into medicinal chemistry synthesis workflows, how they are currently used within MLPDS member companies, and the outlook for this field.
- 1 March 2017
- Published by Elsevier in Drug Discovery Today: Technologies
- Vol. 23, 61-67
The evolution of library design: crafting smart compound collections for phenotypic screens
- 1 March 2017
- Published by Elsevier in Drug Discovery Today: Technologies
- Vol. 23, 61-67
The evolution of library design: crafting smart compound collections for phenotypic screens
- 12 September 2007
- Published by Wiley in ChemInform
- Vol. 38 (40)
Rapid Estimation of Relative Protein—Ligand Binding Affinities Using a High‐Throughput Version of MM‐PBSA.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
- 12 September 2007
- Published by Wiley in ChemInform
- Vol. 38 (40)
Rapid Estimation of Relative Protein—Ligand Binding Affinities Using a High‐Throughput Version of MM‐PBSA.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.